Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Martel

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Ophthalmology|September 15, 2015
Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 StudyJoseph Tauber, Paul Karpecki, Robert Latkany, et al.
Physical Review Applied|November 25, 2014
Three-Dimensional Holographic Refractive-Index Measurement of Continuously Flowing Cells in a Microfluidic ChannelYongjin Sung, Niyom Lue, Bashar Hamza, et al.
BMC Ophthalmology|July 17, 2024
Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trialDavid Wirta, William Lipsky, Melissa Toyos, et al.
Plos One|June 23, 2016
A Worldwide Competition to Compare the Speed and Chemotactic Accuracy of Neutrophil-Like CellsMonica Skoge, Elisabeth Wong, Bashar Hamza, et al.
Ophthalmology|March 8, 2017
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 StudiesRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Ophthalmology|December 23, 2017
ReplyRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Ophthalmology|December 23, 2017
ReplyRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Ophthalmology|December 23, 2017
ReplyRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Ophthalmology|September 15, 2015
Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 StudyJoseph Tauber, Paul Karpecki, Robert Latkany, et al.
Physical Review Applied|November 25, 2014
Three-Dimensional Holographic Refractive-Index Measurement of Continuously Flowing Cells in a Microfluidic ChannelYongjin Sung, Niyom Lue, Bashar Hamza, et al.
BMC Ophthalmology|July 17, 2024
Recombinant human nerve growth factor (cenegermin) for moderate-to-severe dry eye: phase II, randomized, vehicle-controlled, dose-ranging trialDavid Wirta, William Lipsky, Melissa Toyos, et al.
Plos One|June 23, 2016
A Worldwide Competition to Compare the Speed and Chemotactic Accuracy of Neutrophil-Like CellsMonica Skoge, Elisabeth Wong, Bashar Hamza, et al.
Ophthalmology|March 8, 2017
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 StudiesRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Ophthalmology|December 23, 2017
ReplyRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Ophthalmology|December 23, 2017
ReplyRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Ophthalmology|December 23, 2017
ReplyRishi P Singh, Robert Lehmann, Joseph Martel, et al.
Pageof 2